Home LiteratureArticle Details
PMID: 23216814 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes.

Breast cancer research : BCR ·Vol. 14 ·No. 6 ·2012-12-07 ·Pages R155

Fordyce CA, Patten KT, Fessenden TB, DeFilippis R, Hwang ES, Zhao J, Tlsty TD

Abstract

Tumors are characterized by alterations in the epithelial and stromal compartments, which both contribute to tumor promotion. However, where, when, and how the tumor stroma develops is still poorly understood. We previously demonstrated that DNA damage or telomere malfunction induces an activin A-dependent epithelial stress response that activates cell-intrinsic and cell-extrinsic consequences in mortal, nontumorigenic human mammary epithelial cells (HMECs and vHMECs). Here we show that this epithelial stress response also induces protumorigenic phenotypes in neighboring primary fibroblasts, recapitulating many of the characteristics associated with formation of the tumor stroma (for example, desmoplasia). The contribution of extrinsic and intrinsic DNA damage to acquisition of desmoplastic phenotypes was investigated in primary human mammary fibroblasts (HMFs) co-cultured with vHMECs with telomere malfunction (TRF2-vHMEC) or in HMFs directly treated with DNA-damaging agents, respectively. Fibroblast reprogramming was assessed by monitoring increases in levels of selected protumorigenic molecules with quantitative polymerase chain reaction, enzyme-linked immunosorbent assay, and immunocytochemistry. Dependence of the induced phenotypes on activin A was evaluated by addition of exogenous activin A or activin A silencing. In vitro findings were validated in vivo, in preinvasive ductal carcinoma in situ (DCIS) lesions by using immunohistochemistry and telomere-specific fluorescent in situ hybridization. HMFs either cocultured with TRF2-vHMEC or directly exposed to exogenous activin A or PGE2 show increased expression of cytokines and growth factors, deposition of extracellular matrix (ECM) proteins, and a shift toward aerobic glycolysis. In turn, these "activated" fibroblasts secrete factors that promote epithelial cell motility. Interestingly, cell-intrinsic DNA damage in HMFs induces some, but not all, of the molecules induced as a consequence of cell-extrinsic DNA damage. The response to cell-extrinsic DNA damage characterized in vitro is recapitulated in vivo in DCIS lesions, which exhibit telomere loss, heightened DNA damage response, and increased activin A and cyclooxygenase-2 expression. These lesions are surrounded by a stroma characterized by increased expression of α smooth muscle actin and endothelial and immune cell infiltration. Thus, synergy between stromal and epithelial interactions, even at the initiating stages of carcinogenesis, appears necessary for the acquisition of malignancy and provides novel insights into where, when, and how the tumor stroma develops, allowing new therapeutic strategies.

MeSH Terms
Actins/biosynthesis Activins/genetics,metabolism,pharmacology Carcinoma, Intraductal, Noninfiltrating Cell Movement/physiology Cell Transformation, Neoplastic Cells, Cultured Coculture Techniques Cyclooxygenase 2/biosynthesis,metabolism DNA Damage DNA Repair Dinoprostone/pharmacology Epithelial Cells/cytology Fibroblasts/cytology Glycolysis/physiology Humans Mammary Glands, Human/cytology Stress, Physiological Telomere/pathology Telomere Homeostasis
Chemicals
Actins activin A Activins Cyclooxygenase 2 Dinoprostone
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Fordyce Colleen A
Patten Kelley T
Fessenden Tim B
DeFilippis RosaAnna
Hwang E Shelley
Zhao Jianxin
Tlsty Thea D
References (63)
63 references, click to expand
  1. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts.
    Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20009-14 PMID: 21041659
  2. The DNA-damage response in human biology and disease.
    Nature. 2009 Oct 22;461(7267):1071-8 PMID: 19847258
  3. Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract.
    Proc Natl Acad Sci U S A. 1984 Sep;81(17):5435-9 PMID: 6591199
  4. Chromosomal instability in ulcerative colitis is related to telomere shortening.
    Nat Genet. 2002 Oct;32(2):280-4 PMID: 12355086
  5. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression.
    PLoS One. 2009;4(4):e4992 PMID: 19352430
  6. Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer cells.
    Cell Cycle. 2012 Sep 1;11(17):3280-9 PMID: 22894905
  7. Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions.
    Development. 1997 Jul;124(14):2701-8 PMID: 9226441
  8. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.
    Breast Cancer Res Treat. 2002 Jun;74(3):255-69 PMID: 12206515
  9. Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis.
    Antioxid Redox Signal. 2012 Jun 1;16(11):1264-84 PMID: 21883043
  10. Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A.
    Oral Oncol. 2011 Sep;47(9):840-6 PMID: 21727023
  11. Normal or stress-induced fibroblast senescence involves COX-2 activity.
    Exp Cell Res. 2007 Aug 15;313(14):3046-56 PMID: 17560572
  12. Four faces of cellular senescence.
    J Cell Biol. 2011 Feb 21;192(4):547-56 PMID: 21321098
  13. Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors.
    Cancer Res. 2006 Jun 1;66(11):5686-95 PMID: 16740706
  14. Activin A circulating levels in patients with bone metastasis from breast or prostate cancer.
    Clin Exp Metastasis. 2006;23(2):117-22 PMID: 16841234
  15. Tumor stroma and regulation of cancer development.
    Annu Rev Pathol. 2006;1:119-50 PMID: 18039110
  16. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
    Cell. 2005 May 6;121(3):335-48 PMID: 15882617
  17. Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison.
    Int J Cell Biol. 2012;2012:762825 PMID: 22666258
  18. Activin, inhibin and the human breast.
    Mol Cell Endocrinol. 2004 Oct 15;225(1-2):77-82 PMID: 15451571
  19. Telomere DNA content predicts breast cancer-free survival interval.
    Clin Cancer Res. 2007 Dec 1;13(23):7037-43 PMID: 18056180
  20. Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum.
    Mol Hum Reprod. 2008 May;14(5):301-7 PMID: 18359784
  21. Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells.
    J Surg Res. 2007 Jun 15;140(2):220-6 PMID: 17418864
  22. Tumor microenvironment and progression.
    J Surg Oncol. 2011 May 1;103(6):468-74 PMID: 21480238
  23. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells.
    J Clin Invest. 1995 Feb;95(2):859-73 PMID: 7532191
  24. Recent advances in telomere biology: implications for human cancer.
    Curr Opin Oncol. 2004 Jan;16(1):32-8 PMID: 14685090
  25. Fibroblasts in cancer.
    Nat Rev Cancer. 2006 May;6(5):392-401 PMID: 16572188
  26. The p53 network: cellular and systemic DNA damage responses in aging and cancer.
    Trends Genet. 2012 Mar;28(3):128-36 PMID: 22265392
  27. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes.
    Nature. 2001 Feb 1;409(6820):633-7 PMID: 11214324
  28. Hallmarks of senescence in carcinogenesis and cancer therapy.
    Oncogene. 2004 Apr 12;23(16):2919-33 PMID: 15077154
  29. Telomere length and risk of incident cancer and cancer mortality.
    JAMA. 2010 Jul 7;304(1):69-75 PMID: 20606151
  30. Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1.
    BMC Med Genomics. 2010 Nov 03;3:51 PMID: 21047417
  31. Serum and tissue expression of activin a in postmenopausal women with breast cancer.
    J Clin Endocrinol Metab. 2002 May;87(5):2277-82 PMID: 11994376
  32. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Oncol Rep. 2005 Jan;13(1):81-8 PMID: 15583806
  33. Immune cells as mediators of solid tumor metastasis.
    Cancer Metastasis Rev. 2008 Mar;27(1):11-8 PMID: 18066650
  34. MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone.
    Anticancer Res. 2007 May-Jun;27(3B):1519-25 PMID: 17595770
  35. The consensus coding sequences of human breast and colorectal cancers.
    Science. 2006 Oct 13;314(5797):268-74 PMID: 16959974
  36. Telomere content correlates with stage and prognosis in breast cancer.
    Breast Cancer Res Treat. 2006 Sep;99(2):193-202 PMID: 16752076
  37. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production.
    Cell Cycle. 2012 Aug 15;11(16):3019-35 PMID: 22874531
  38. Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer.
    Subcell Biochem. 2007;42:93-126 PMID: 17612047
  39. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
    PLoS Biol. 2008 Dec 2;6(12):2853-68 PMID: 19053174
  40. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.
    Cancer Res. 1999 Oct 1;59(19):5002-11 PMID: 10519415
  41. Targeting hypoxic cells through the DNA damage response.
    Clin Cancer Res. 2010 Dec 1;16(23):5624-9 PMID: 20876254
  42. Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.
    Haematologica. 2012 Jan;97(1):56-63 PMID: 21933855
  43. Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program.
    Cancer Cell. 2004 Mar;5(3):263-73 PMID: 15050918
  44. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma.
    Cell Cycle. 2009 Dec;8(23):3984-4001 PMID: 19923890
  45. DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions.
    Cancer Prev Res (Phila). 2010 Feb;3(2):190-201 PMID: 20028875
  46. Cellular senescence in cancer and aging.
    Cell. 2007 Jul 27;130(2):223-33 PMID: 17662938
  47. Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment.
    Int J Biochem Cell Biol. 2011 Jul;43(7):1045-51 PMID: 21300172
  48. COX-2 overexpression increases motility and invasion of breast cancer cells.
    Int J Oncol. 2005 May;26(5):1393-9 PMID: 15809733
  49. Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer.
    J Bone Miner Res. 2009 Jul;24(7):1180-93 PMID: 19257827
  50. Senescent cells as a source of inflammatory factors for tumor progression.
    Cancer Metastasis Rev. 2010 Jun;29(2):273-83 PMID: 20390322
  51. Activation of fibroblasts in cancer stroma.
    Exp Cell Res. 2010 Oct 15;316(17):2713-22 PMID: 20451516
  52. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion.
    Nat Cell Biol. 2009 Aug;11(8):973-9 PMID: 19597488
  53. Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors.
    Cancer Cell. 2007 Nov;12(5):479-91 PMID: 17996651
  54. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
    Nature. 2006 Nov 30;444(7119):633-7 PMID: 17136093
  55. Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment.
    Cancer Biol Ther. 2010 Sep 15;10(6):537-42 PMID: 20861671
  56. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium.
    Cancer Res. 2003 May 15;63(10):2347-50 PMID: 12750248
  57. Telomere shortening occurs early during breast tumorigenesis: a cause of chromosome destabilization underlying malignant transformation?
    J Mammary Gland Biol Neoplasia. 2004 Jul;9(3):285-96 PMID: 15557801
  58. Impact of cyclooxygenase-2 in breast cancer.
    Anticancer Res. 2011 Dec;31(12):4359-67 PMID: 22199301
  59. Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes.
    Mod Pathol. 2011 Feb;24(2):194-200 PMID: 21057458
  60. Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer.
    Angiogenesis. 2010 Mar;13(1):43-58 PMID: 20229258
  61. Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.
    Cancer Res. 2003 Apr 1;63(7):1596-601 PMID: 12670910
  62. Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma.
    Mod Pathol. 2006 Jun;19(6):772-9 PMID: 16557277
  63. Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis.
    Exp Biol Med (Maywood). 2006 May;231(5):534-44 PMID: 16636301
Article Info
Journal
Breast cancer research : BCR
Abbr.
Breast Cancer Res
ISSN
1465-542X
Published
2012-12-07
Epub
2012-00-07
Pages
R155
Language
English
Region
England
NLM ID
100927353
PMCID
PMC3786321
Subset
IM
Grants
NCI NIH HHS · P01 CA107584 · United States
NCI NIH HHS · R01 CA097214 · United States
NCI NIH HHS · U54 CA143803 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]